NPPG Position Statement on drug treatments for COVID-19 in children in the UK  (updated 28th January 2022)

Clinical papers and information is starting to emerge regarding the use of various medications that could potentially be used to treat COVID-19 

To avoid duplication of work with regards to management of paediatric COVID-19 patients, NPPG and PICU pharmacists are contributing and supporting current guidance being developed – see the RCPCH Covid pages and the Specialist Pharmacy Services pages for more information

The COVID-19 section of the NPPG message board may provide further information for pharmacists. 

Clinical pharmacy for critical care NPPG Paediatric Critical Care Group package

These links below are provided for information only. None of these sites are under the control of NPPG and as such NPPG cannot be responsible for any actions taken as a result of these links.

Recovery trial

  • RECOVERY (COVID-19/PIMS-TS) Trial website – no password/registration needed.  All up to date documents, protocol etc is available here – frequent amendments!  Paediatric appendix 3 contains dosing information.

Recent guidance /links relating to COVID-19


error: Content is protected !!